amifampridine 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet
- RxCUI
- 2106343
- RxNorm name
- amifampridine 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet
- Display name
- amifampridine 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet
- Full name
- amifampridine 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Firdapse | AMIFAMPRIDINE PHOSPHATE | Catalyst Pharmaceuticals, Inc. | f015fe60-3128-4a43-8c31-19fc6b5def3f | 2026-04-16 | Warnings, Adverse reactions | 2106343 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f015fe60-3128-4a43-8c31-19fc6b5def3f | amifampridine 10 MG Oral Tablet [PSN] · amifampridine 10 MG Oral Tablet [SCD] · amifampridine 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet [SY] | 3 | 15 | These highlights do not include all the information needed to use FIRDAPSE ® safely and effectively. See full prescribing information for FIRDAPSE ® . FIRDAPSE ® (amifampridine) tablets, for oral use Initial U.S. Approval: 2018 | 20260416 |